Observational Study of Efficacy and Safety of Travogen Cream and Travocort Cream in the Treatment of Mycoses

Observational Study of the Efficacy, Safety and Tolerance of Travogen Cream (Isoconazole) and Travocort Cream (Isoconazole, Diflurcortolone) in the Treatment of Patients With Local Skin Mycosis of Various Etiology and Localization

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00722189

Enrollment

900

Registered

2008-07-25

Start date

2008-07-31

Completion date

2009-02-28

Last updated

2023-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin Mycoses

Keywords

Mycoses

Brief summary

An assessment of the efficacy and safety of Travogen cream and Travocort cream in the treatment of local skin mycoses

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Diagnosis of skin mycosis

Exclusion criteria

* Allergies to study medication

Design outcomes

Primary

Measure	Time frame
Efficacy of Travogen / Travocort in the treatment of skin mycoses / Travogen Cream and Travocort Cream will be prescribed by a physician	Baseline to end of study

Secondary

Measure	Time frame
Patient satisfaction	Baseline to end of study

Countries

Russia

Outcome results